Press Releases

Research and Markets: Pharmaceutical and Biotechnology Construction Sector Report - UK 2012-2016 Analysis

DUBLIN--(BUSINESS WIRE)-- Research and Markets ( has announced the addition of the "Pharmaceutical and Biotechnology Construction Sector Report - UK 2012-2016 Analysis" report to their offering.

AMA Research are pleased to announce the publication of the 1st Edition of a new report: Pharmaceutical and Biotechnology Construction Sector Report - UK 2012-2016 Analysis. The report should be of particular interest to construction companies and their supply chains operating in the UK Life Sciences sector, and to suppliers of laboratory and allied products.

Key areas in the report:

- Introduction to pharmaceutical, medical technology, medical and industrial biotechnology sectors - market size, key players and geographical areas of concentration.

- Overview of main manufacturing and R&D facilities in UK.

- Analysis of Government resource and capital funding for science and research.

- Review of challenges facing the pharmaceutical sector.

Areas of particular interest:

- Major contractors, consultants, architects and product suppliers involved in the pharmaceutical and biotechnology sectors.

- Capital Expenditure levels in the pharmaceutical market.

- Construction costs and issues in the design of pharmaceutical R&D/manufacturing facilities including legislation, regulatory requirements, containment and environmental issues, cleanroom and laboratory design.

- Profiles of top pharmaceutical/biotechnology companies operating in the UK - revenue, capital expenditure, key manufacturing & R&D facilities in UK, future strategy, expansion plans, forward pipelines etc.

Key Topics Covered:

1. Introduction

2. Summary And Future Prospects

3. Market Size And Overview

4. Leading Companies/Universities In The Pharmaceutical And Biotechnology Sectors

5. Construction Activity In The Pharmachem And Biotechnology Sector

6. Construction Capability And Supply In The Pharmaceutical & Biotechnology Sector

Leading pharmaceutical and biotechnology companies mentioned in the report include:

- AstraZeneca

- Abbott Laboratories

- Abcam

- ABS Laboratories

- ACM Global Central Lab

- Aesica Pharmaceuticals

- Allergan

- Bayer CropScience

- Bells Healthcare

- Calea (UK)

- Cancer Research Technology

- Cantab Biopharmaceuticals

- Carbogen Amcis

- Cobra Biomanufacturing

- Convergence Pharmaceuticals

- Darchem

- Eli Lilly

- GlaxoSmithKline

- Huntingdon Life Sciences

- Intercytex

- Isis Innovation

- Life Technologies

- Lonza Biologics

- MedImmune

- Merck & Co

- Mundipharma International

- Norbrook Pharmaceuticals

- Novartis UK

- NuPharm Laboratories

- Oxygen Healthcare

- Penn Pharma

- Pfizer

- Pharmaserve Northwest

- PsiOxus Therapeutics

- Reading Scientific Services

- Recipharm

- Redx Pharma

- Renovo

- Roche

- Sanofi Aventis

- Sareum

- Teva Pharmaceutical Industries

- TPP Global Development

- UCB Pharma

- Unilever.

Leading construction companies and consultants mentioned in the report include:

- ABB Group



- Ardmac

- Bassaire


- Bilfinger Berger

- Cavendish Engineers

- Clean Air Technologies

- Clean Modules

- Clean Room Construction

- Cleanroom Design & Construction

- Cleanroom Solutions

- ClearSphere

- Enbloc Cleanrooms

- Foster Wheeler

- Jacobs Engineering

- Kier Group

- Lend Lease

- M+W UK

- Mach-Aire

- Merit Merrell

- Nuvia

- Precision Cleanrooms


- Shepherd Construction

- Sheppard Robson

- Validair

- Wilson Mason.

For more information visit

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Construction

Source: Research and Markets